EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Short-Term Outcomes of Faricimab Treatment in Aflibercept-Refractory Eyes with Neovascular Age-Related Macular Degeneration

Maya Kishi, Akiko Miki iD, Aya Kamimura, Mina Okuda, Wataru Matsumiya, Hisanori Imai iD, Sentaro Kusuhara iD, Makoto Nakamura iD

Journal of Clinical Medicine · 06.08.2023 · 12 (15) · 5145

DOI: 10.3390/jcm12155145 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 06.08.2023. Verfasst von Maya Kishi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Division of Ophthalmology, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To evaluate the functional and anatomical effects of switching to faricimab for patients with neovascular age-related macular degeneration (nAMD) refractory to intravitreal aflibercept, this retrospective study evaluated patients with nAMD who received intravitreal injections of aflibercept (IVA) every

Schlagwörter

Stichwörter der Autor:innen

afliberceptage-related macular degenerationanti-vascular endothelial growth factorfaricimab

Autor:innen und Institutionen

  • Department of Surgery, Division of Ophthalmology, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.

ORCID-Profile: Akiko Miki, Hisanori Imai, Sentaro Kusuhara, Makoto Nakamura

Zitieren

APA

Kishi, M., Miki, A., Kamimura, A., Okuda, M., Matsumiya, W., Imai, H., Kusuhara, S., & Nakamura, M. (2023). Short-Term Outcomes of Faricimab Treatment in Aflibercept-Refractory Eyes with Neovascular Age-Related Macular Degeneration. Journal of Clinical Medicine, 12(15), 5145. https://doi.org/10.3390/jcm12155145

Vancouver

Kishi M, Miki A, Kamimura A, Okuda M, Matsumiya W, Imai H, et al. Short-Term Outcomes of Faricimab Treatment in Aflibercept-Refractory Eyes with Neovascular Age-Related Macular Degeneration. Journal of Clinical Medicine. 2023;12(15):5145. doi:10.3390/jcm12155145

BibTeX
@article{Kishi2023,
  author = {Kishi, Maya and Miki, Akiko and Kamimura, Aya and Okuda, Mina and Matsumiya, Wataru and Imai, Hisanori and Kusuhara, Sentaro and Nakamura, Makoto},
  title = {Short-Term Outcomes of Faricimab Treatment in Aflibercept-Refractory Eyes with Neovascular Age-Related Macular Degeneration},
  journal = {Journal of Clinical Medicine},
  year = {2023},
  volume = {12},
  number = {15},
  pages = {5145},
  doi = {10.3390/jcm12155145}
}
Kostenlos starten →